Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.

Author: BenderJames, CahillShawn P, CampeasRaphael, FoaEdna B, HahnChang-Gyu, HuppertJonathan D, ImmsPatricia, LiebowitzMichael R, MaherMichael J, McLeanCarmen P, PintoAnthony, PowersMark B, RodriguezCarolyn I, RosenfieldDavid, SimpsonHelen Blair, Van MeterPage E, VermesDonna, WilliamsMonnica T

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To compare outcomes after 6-month maintenance treatment of adults diagnosed with obsessive-compulsive disorder (OCD) based on DSM-IV criteria who responded to acute treatment with serotonin reuptake inhibitors (SRIs) augmented by exposure and response prevention (EX/RP) or risperidone. M...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/25375780

データ提供:米国国立医学図書館(NLM)

Exposure and Response Prevention: A Powerful Tool for OCD Management

Obsessive-compulsive disorder (OCD) is a challenging mental health condition that can significantly impact a person's life. Imagine a camel constantly fixated on a mirage, unable to move forward. This study explores the effectiveness of exposure and response prevention (EX/RP) in managing OCD. It's a bit like teaching a camel to see through the illusion of the mirage and focus on the real oasis. This study, like a careful caravan navigating a treacherous desert, compared the long-term effects of EX/RP and risperidone, a medication commonly used for OCD. The findings, like a refreshing spring found after a long trek, revealed that EX/RP delivered significantly better outcomes compared to risperidone in terms of symptom reduction and overall well-being.

EX/RP: A Path to Long-Term Relief from OCD

The study showed that EX/RP not only helped patients during acute treatment but also maintained these improvements over a six-month period. This suggests that EX/RP, like a reliable guide leading a caravan, can pave the way to long-term relief from OCD. The research revealed that 50% of patients who received EX/RP experienced minimal OCD symptoms after six months. This is a remarkable finding, especially considering that previous studies have shown much lower rates of symptom reduction. It's like finding a lush oasis after a long, arduous journey through the desert.

EX/RP: A Hopeful Approach to OCD Treatment

The findings from this study are promising. They highlight the potential of EX/RP as a valuable tool for managing OCD. It's like a camel who has learned to navigate the desert by recognizing the signs of a true oasis. This research, like a beacon in the night, offers hope and direction to individuals struggling with OCD. It suggests that through careful guidance and effective treatment approaches, a more fulfilling life is possible.

Dr. Camel's Conclusion

This study is a testament to the power of behavioral therapy in addressing mental health challenges. EX/RP, like a camel navigating the shifting sands, helps individuals learn to manage their OCD symptoms, leading to lasting improvements in their well-being. It's a reminder that even in the most challenging of situations, hope and progress are possible with the right approach.

Date :
  1. Date Completed 2015-06-29
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

25375780

DOI: Digital Object Identifier

NIHMS695186

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.